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ABSTRACT
Objective Although polymorphisms of the NOD2 gene
predispose to the development of ileal Crohn’s disease,
the precise mechanisms of this increased susceptibility
remain unclear. Previous work has shown that transcript
expression of the Paneth cell (PC) antimicrobial peptides
(AMPs) α-defensin 4 and α-defensin-related sequence
10 are selectively decreased in Nod2−/− mice. However,
the specific mouse background used in this previous
study is unclear. In light of recent evidence suggesting
that mouse strain strongly influences PC antimicrobial
activity, we sought to characterise PC AMP function in
commercially available Nod2−/− mice on a C57BL/6 (B6)
background. Specifically, we hypothesised that Nod2−/−
B6 mice would display reduced AMP expression and
activity.
Design Wild-type (WT) and Nod2−/− B6 ileal AMP
expression was assessed via real-time PCR, acid urea
polyacrylamide gel electrophoresis and mass
spectrometry. PCs were enumerated using flow
cytometry. Functionally, α-defensin bactericidal activity
was evaluated using a gel-overlay antimicrobial assay.
Faecal microbial composition was determined using 454-
sequencing of the bacterial 16S gene in cohoused WT
and Nod2−/− littermates.
Results WT and Nod2−/− B6 mice displayed similar PC
AMP expression patterns, equivalent α-defensin profiles,
and identical antimicrobial activity against commensal
and pathogenic bacterial strains. Furthermore, minimal
differences in gut microbial composition were detected
between the two cohoused, littermate mouse groups.
Conclusions Our data reveal that Nod2 does not
directly regulate PC antimicrobial activity in B6 mice.
Moreover, we demonstrate that previously reported
Nod2-dependent influences on gut microbial
composition may be overcome by environmental factors,
such as cohousing with WT littermates.
INTRODUCTION
Crohn’s disease (CD) is a chronic intestinal inflam-
matory disorder that results from the interaction of
numerous genetic and environmental factors. Of the
genetic loci associated with CD, single nucleotide
polymorphisms (SNPs) of the NOD2 gene display
the strongest correlation with disease development.1
Although NOD2 is found primarily in monocytes
and dendritic cells, it is also constitutively expressed
in small intestine epithelial cells known as Paneth
cells (PC).2 PCs contribute to mucosal enteric
immunity through the production of antimicrobial
peptides (AMPs). The most potent class of
PC-derived AMPs are the α-defensins (cryptdins).3
Genetic alterations that diminish PC α-defensin
activity are associated with compositional changes
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Significance of this study
What is already known on this subject?
▸ Polymorphisms of nucleotide-binding,
oligomerisation domain 2 (NOD2) are the most
frequently replicated disease alleles associated
with Crohn’s disease (CD).
▸ NOD2 is highly expressed in Paneth cells (PC),
which are small intestinal epithelial cells that
secrete a multitude of antimicrobial molecules into
the gut lumen. The most potent class of these
antimicrobial peptides (AMP) is the α-defensins.
▸ Previous work using Nod2-deficient mice
suggests that Nod2 regulates PC α-defensin
expression, which in turn modulates the
composition of the gut microbiota.
What are the new findings?
▸ When Nod2-deficient mice are examined on
pure genetic background (C57BL/6), they show
no differences in α-defensin levels relative to
wild-type (WT) mice.
▸ With the exception of the molecule cryptdin-
related sequence 1C, expression of all major PC
AMP classes are unaffected by Nod2 status in
C57BL/6 mice.
▸ The composition of the mouse faecal
microbiota is independent of Nod2 status when
WT and Nod2−/− littermates are housed in the
same cages.
How might it impact on clinical practice in
the foreseeable future?
▸ This work guides future studies of CD
pathogenesis by underscoring the importance of
controlling for mouse genetic background and
housing conditions when studying PCs in mouse
models of CD risk alleles.
▸ The finding that environmental influences can
overcome the impact of host genetics on gut
microbial composition suggests that microbial
modulation strategies (such as probiotics) are
feasible, even in the face of strong genetic
influences on the intestinal microbiota.
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in the intestinal microbiota.4 Because components of the gut
microbiota are believed to drive intestinal inflammation in CD,
dysregulation of α-defensin function may be an important factor
in CD pathogenesis.5
Although the precise regulation of α-defensin activity remains
unclear, various studies have suggested a role for NOD2 in
modulating the function of these molecules. Previous reports
have demonstrated that ileal CD patients possess attenuated
expression of the two human PC α-defensins (HD-5 and
HD-6),6 with the greatest reduction in patients with a specific
NOD2 polymorphism.7 Subsequent work using a mouse model
of Nod2-deficiency revealed that Nod2−/− mice also display
reduced mRNA expression of particular α-defensins.8
Specifically, Nod2−/− mice exhibit ∼100-fold less transcript
expression of the molecules α-defensin 4 (Defa4) and
α-defensin-related sequence 10 (Defa-rs10) relative to wild-type
(WT) mice.
Despite the evidence supporting the role of NOD2 in
α-defensin regulation, these findings remain subject to a degree
of uncertainty. First, a follow-up study in patients with ileal CD
demonstrated that reduced α-defensin expression is associated
with inflammation, as opposed to NOD2 status.9 Second, the
precise background of the Nod2−/− mice used to implicate
Nod2 as a regulator of α-defensin expression is unclear. This is
critical, because recent work has demonstrated that mouse back-
ground strain plays a key role in defining α-defensin expression
patterns.10 The Nod2−/− mice used in the original study were
constructed using 129S1/Sv-derived W9.5 embryonic stem (ES)
cells injected into C57BL/6 (B6) blastocysts, leaving open the
possibility that these animals were on a mixed background at
the time of analysis. Therefore, in light of the confounding vari-
able of a mixed genetic background, the precise role of Nod2 in
regulating mouse α-defensin expression remains unclear. Further
characterisation of the impact of Nod2 on AMP expression is
essential to define its precise function in PC biology, as well as
its role in CD pathogenesis.
In the present study, we sought to determine the regulatory
effects of Nod2 on mouse PC-derived AMP expression, control-
ling for background strain. This was accomplished by evaluating
the PC AMP repertoire of Nod2−/− versus WT littermates on a
pure B6 background. These animals are available commercially
through Jackson Labs, and represent the original Nod2−/−
strain8 that has since been backcrossed to completion on the B6
background. We hypothesized that these Nod2−/− B6 mice
would display diminished AMP expression and attenuated PC
function relative to their WT counterparts. Unexpectedly, we
found that the majority of mouse PC-derived AMP classes
showed equivalent expression in Nod2−/− and WT B6 mice.
Furthermore, α-defensin antimicrobial activity and global faecal
microbial composition were also strikingly similar in both
Nod2−/− and WT groups. These findings suggest that PC anti-




Nod2+/+ (WT) and Nod2−/− B6 mice were obtained from
Jackson Laboratories (Bar Harbor, ME), and were housed in
specific pathogen-free conditions consistent with guidelines
established by the American Association for Laboratory Animal
Care and Research. WT and Nod2−/− mice were crossed to gen-
erate Nod2+/− heterozygous animals, which were then bred to
produce WT and Nod2−/− littermates that were housed together
for comparison in our studies (see online supplementary figure
S1). Importantly, Nod2+/− offspring were recrossed to generate
a continuous pool of WT and Nod2−/− littermates, all derived
ultimately from the same founders. This is in contrast with pre-
vious work, which used littermates from a single Nod2+/− het-
erozygous cross to start homozygous Nod2+/+ and Nod2−/−
lines that were housed separately for the duration of the study.11
This distinction is critical, as the mice in our study were never
housed separately based on Nod2 status alone, allowing for
more consistent environmental exposure to both experimental
groups. All mice were housed in the same animal room and
sacrificed within 8–12-weeks of age. Nod2 genotyping was per-
formed on genomic DNA extracted from mouse-tail clippings
(see online supplementary methods). Identification of WT and
Nod2-null mice was confirmed by PCR product sequencing (see
online supplementary figures S2 and S3).
Quantitative reverse-transcriptase PCR
Quantitative RT-PCR was performed using TaqMan or SYBR
Green assays (Applied Biosystems, Foster City, California, USA)
per manufacturer’s instructions. Details are described in the
online supplementary methods. β-Actin was used as an internal
control, and ΔΔCt values were calculated to obtain fold changes
relative to the baseline group.
Acid urea polyacrylamide gel electrophoresis
Ileal tissue protein was extracted as previously described.10
Protein extracts were analysed by acid urea-polyacrylamide gel
electrophoresis (AU-PAGE) followed by mass spectrometric ana-
lysis using matrix assisted laser desorption ionisation-time of
flight tandem mass spectrometry (MALDI-TOF/TOF MS).
Details are provided in the online supplementary methods.
Immunohistochemistry
Primary staining was accomplished using a rabbit polyclonal
antilysozyme (Lyz) antibody (1:1500, Diagnostic BioSystems,
Pleasanton, California, USA). Biotinylated antirabbit IgG was
used as a secondary antibody (1:200, Vector Laboratories,
Burlingame, California, USA). Details are provided in the online
supplementary methods.
Flow cytometry
Ileal epithelial cells were isolated using EDTA/dispase digestion
as previously described.12 Cells were fixed in 4% paraformalde-
hyde for 15 min and resuspended in saponin permeabilisation
buffer (Invitrogen, Carlsbad, California, USA) with Lyz-FITC
antibody (1:10, Dako, Carpenteria, California, USA) and
CD45-A647 antibody (1:1000, BD Biosciences, San Jose,
California, USA) for 30 min. Flow analysis was performed per
established protocols.13
Bactericidal gel overlay assay
Bacterial strains were grown to mid-log phase in trypticase soy
broth media and resuspended in warm 1% low-melt agarose as
previously described.10 Ileal protein samples were prepared by
electrophoresis on a small-scale AU-PAGE gel. Gel overlay plates
were incubated overnight at 37°C and imaged for
band-associated zones of bacterial clearance. Details are pro-
vided in the online supplementary methods.
Bacterial composition analyses
Total DNA was extracted from faecal samples as previously
described.14 Bacterial composition of isolated DNA samples was
characterised by PCR amplification of the V1-3 variable region
of the 16S rRNA gene.15 Taxonomic and phylogenetic analyses
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of 16S rRNA sequence data are detailed in the online supple-
mentary methods.16 17
Statistics
AMP expression and PC number comparisons were performed
using GraphPad Prism 5 (GraphPad, San Diego, California,
USA). All variables were found to have a normal distribution.
Means were compared using Student’s t test (2-tailed), and are
expressed as mean±SEM.
RESULTS
Mouse PC AMP expression is predominantly independent of
Nod2
To determine the effects of Nod2 deletion on PC AMP gene
expression, qRT-PCR was used to quantitate ileal AMP levels in
WTand Nod2−/− B6 mice. The major PC AMP classes expressed
in B6 mice include: α-defensins (cryptdins), cryptdin-related
sequence peptides (CRS1C and CRS4C), lysozyme-P (Lyz),
angiogenin-4 (Ang4) and regenerating islet-derived protein 3 γ
(Reg3γ).18 Consistent with earlier reports in CD patients6 and
Nod2−/− mice,19 we observed no differences in Lyz or Reg3γ
expression between Nod2−/− and WT mice (figure 1A,B).
Furthermore, Nod2-deficiency did not alter transcription of the
Ang4 gene (figure 1C). Interestingly, Nod2 deletion also did not
affect global levels of α-defensin transcripts (figure 1D), using
primers that detect all known PC α-defensin genes.20
By contrast with the AMPs described above, mRNA levels of
the CRS peptides analysed in this study did display a unique
expression pattern in Nod2−/− mice. Specifically, transcript
levels of the CRS1C subgroup were significantly decreased in
Nod2−/− mice relative to WT controls (∼25% reduction,
p<0.05) (figure 1E). Furthermore, we were unable to detect
transcripts of the second CRS peptide subgroup, CRS4C, in
either WT or Nod2−/− B6 mice (figure 1F), though this sub-
group was prominently expressed in the ilea of 129/SvEv mice
(see online supplementary figure S4A). This is particularly
important because a member of this subgroup, Defa-rs10, has
been reported to be reduced in Nod2−/− mice relative to WT
controls.8 Despite multiple attempts, we were unable to detect
Defa-rs10 transcripts in either WT or Nod2−/− B6 mice, though
this transcript was also highly expressed in 129/SvEv animals
(see online supplementary figure S4A).
In summary, with the exception of the CRS1C group, we
failed to reject the null hypothesis that the major mouse AMP
classes had equal mRNA expression. Moreover, the 95% CIs of
the mean AMP levels for the WT and Nod2−/− groups were
highly overlapping (see online supplementary table S1), suggest-
ing that if there is a real difference in AMP expression between
WTand Nod2−/− mice, it is small in magnitude.
Mouse PC α-defensin expression is independent of Nod2
Because previous work has demonstrated reduced expression of
the α-defensin Defa4 in Nod2−/− mice,8 it was surprising to find
equivalent global α-defensin levels in Nod2−/− and WT mice. To
determine if a compensatory induction of specific α-defensin
isoforms could explain these findings, we next measured mRNA
levels of selected α-defensin AMPs from 3 different phylogen-
etic groups (Defa4, Defa3 and Defa5).21 As shown in figure 2A,
Defa4 transcripts were undetected in both WT and Nod2−/−
mice, though were present in 129/SvEv animals (see online
supplementary figure S4B). Because Defa4 is expressed exclu-
sively in non-B6 mouse strains,10 21 we also quantified transcript
expression of Defa20, which is the B6 homologue of Defa4.
Transcripts levels of Defa20 were equivalent in WT and Nod2−/−
mice (figure 2B). Finally, Defa3 and Defa5 mRNA levels also
showed no statistical differences between experimental groups
(figures 2C,D).
At the protein level, PC α-defensins were assessed using
AU-PAGE, which localises α-defensins to a series of bands at the
cathodal end of the gel.22 Figure 2E shows that α-defensin
banding patterns were identical between WT and Nod2−/− mice.
Subsequent MALDI-TOF/TOF MS analysis demonstrated that
the identities of the α-defensin bands in WT and Nod2−/− mice
were also indistinguishable (see online supplementary table S2).
This is further highlighted in online supplementary figure S4C,
which reveals that pooled samples of WT B6 and Nod2−/− B6
ileal protein extracts have a distinct banding pattern from those
of WT 129 mice. This supports the premise that mouse strain
profoundly influences the ileal α-defensin profile, while
Nod2-deficiency does not result in measurable changes in the
expression of these molecules.
Nod2 does not regulate PC numbers
Our findings thus far demonstrate minimal differences in PC
AMP expression in ileal tissue from WT and Nod2−/− mice.
However, if Nod2-deficiency results in decreased AMP expres-
sion at a cellular level, it is possible that a compensatory increase
in PC numbers could result in similar total AMP levels between
WT and Nod2−/− groups. To ensure that alterations in PC
number were not masking some degree of Nod2-mediated AMP
regulation, we enumerated PCs in WT and Nod2−/− mice. H&E
staining of ileal sections from both experimental groups showed
that WT and Nod2−/− mice have normal tissue architecture, and
display no signs of inflammation (figure 3A). Quantification of
Figure 1 Paneth cell (PC) antimicrobial peptide transcript expression
is primarily unaffected by Nod2. Ileal transcript levels of (A) lysozyme-P
(Lyz); (B) regenerating islet-derived protein 3 gamma (Reg3γ);
(C) angiogenin 4 (Ang4); (D) total PC α-defensins (PanCrp);
(E) cryptdin-related sequence (CRS)1C and (F) CRS4C are shown for
wild-type (WT) and Nod2−/− mice (n=8–10 mice/group). CRS4C was
not detected (ND) in any animal. Copy number is normalised to β-actin
and expressed as a fold Δ relative to the WT group. Data are shown as
means with SEM. *p<0.05; N.S.—not significant (p>0.6), based on
Student’s t test.
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intestinal crypts revealed no differences between the two groups
of mice, and therefore, no effect of Nod2 on crypt development
(figure 3B). Using anti-Lyz staining as a PC marker, immunohis-
tochemistry displayed neither ectopic placement of PCs, nor
hyperplastic growth of these cells (figure 3C). Furthermore,
there was no significant difference in the number of Lyz+ cells
per crypt between WTand Nod2−/− mice (figure 3D). Finally, to
minimise the bias of counting PCs from selected high-power
fields, flow cytometry of epithelial cell preparations from the
entire ileum of WT and Nod2−/− mice was performed. Using
CD45 as a haematopoietic cell maker, PCs were identified as the
Lyz+CD45− cell fraction (figure 3E). Quantification from three
independent experiments confirmed that WT and Nod2−/− ilea
contained an equivalent percentage of PCs within their epithelia
(figure 3F). Total numbers of epithelial cells from each group
were not significantly different. In summary, this analysis
demonstrates that Nod2 does not regulate α-defensin expression
on a per-cell basis.
PC α-defensin antimicrobial activity is unaffected by Nod2
The similarity in the AU-PAGE banding pattern of the
α-defensin region between WT and Nod2−/− mice indicates that
Nod2 does not regulate post-translational processing or
conformational folding of PC α-defensins. To confirm that
Nod2-deficiency does not affect the functional microbicidal
activity of PC α-defensins, we tested the ability of ileal protein
extracts from WT and Nod2−/− mice to inhibit the growth of
commensal and pathogenic bacterial strains. Specifically, we
assessed α-defensin antimicrobial activity against the commensal
bacterium Escherichia coli strain NC101 (which has been shown
to induce intestinal inflammation in genetically engineered
mice),23 as well as the intestinal pathogens Listeria monocyto-
genes and Salmonella enterica. To test α-defensin antimicrobial
activity against these organisms, we excised the α-defensin zone
of an AU-PAGE minigel (figure 4A), overlaid this onto agarose
plates of confluent bacteria, and observed for zones of bacterial
inhibition. Figure 4B–D demonstrates comparable zones of
α-defensin-mediated bacterial inhibition for all tested bacteria,
regardless of host Nod2 status. Therefore, Nod2 does not influ-
ence the bacteriostatic activity of PC α-defensins against relevant
proinflammatory commensal and pathogenic bacterial strains. It
is interesting to note that Nod2−/− mice are reported to have
increased susceptibility to oral L monocytogenes infection.8 The
present data suggest this is unlikely due to defective α-defensin
antimicrobial function.
Nod2 has minimal effects on global faecal microbial
composition
Given the similarities in PC AMP function between WT and
Nod2−/− mice, we next sought to determine if there were differ-
ences in the global microbial composition of our experimental
groups. Previous studies have demonstrated that Nod2−/− mice
have alterations of their intestinal microbiota relative to WT
animals.11 24 However, as described in our methods, the breed-
ing strategy used in the present study allows for more rigorous
control of environmental influences through cohousing of
Nod2−/− and WT littermates. By principal coordinates analysis
of samples based on deep sequencing of the 16S gene, it
appeared that the cage the mice were housed in had a stronger
effect on microbial community composition than did the WTor
Nod2−/−genotype (figure 5). Indeed, the null hypothesis that the
cage has no effect on gut microbial structure was rejected for
five of the first eight coordinates at a 10% false discovery rate
(table 1). By contrast, we failed to reject the null hypothesis that
genotype has no effect on microbial composition for any of the
first 15 coordinates at a p<0.05 threshold (table 2). This was
also true at the individual taxa level, where we failed to reject
the null hypothesis that individual taxa were not significantly
different between WT and Nod2−/− at a 10% false discovery
rate (see online supplementary table S3). These data suggest that
the cage environment plays a stronger role in structuring the
microbial community than the absence of Nod2 expression.
DISCUSSION
Polymorphisms of the NOD2 gene remain the most replicated
risk alleles for the development of CD.25 Despite this high
reproducibility, the precise mechanisms by which NOD2 dys-
function increases CD susceptibility are unclear. Previous work
using Nod2−/− mice suggests a key role for Nod2 in the tran-
scriptional regulation of specific PC α-defensins.8 However, in
the present study, we demonstrate that there are no profound
effects of Nod2-deficiency on PC α-defensin mRNA expression,
protein levels, or antimicrobial activity when mouse background
is strictly controlled. Moreover, using cohoused WTand Nod2−/−
littermates, we reveal that local cage conditions outweigh
Nod2-mediated effects on faecal microbial composition.
Figure 2 Paneth cell α-defensin expression is independent of Nod2.
mRNA expression of α-defensin isoforms (A) Defa4; (B) Defa20; (C)
Defa3; and (D) Defa5 in the ileum of wild-type (WT) and Nod2−/− mice
(n=8–10 mice/group). Copy number is normalised to β-actin and
expressed as a fold Δ relative to the WT group. Data are shown as
means with SEM. ND— not detected; NS— not significant (p>0.1),
based on Student’s t test. (E) acid urea-polyacrylamide gel
electrophoresis demonstrates peptide expression patterns of α-defensin
isoforms in the ileum of WT and Nod2−/− mice. First lane is
recombinant Defa4 control; each additional lane represents an
individual mouse. Individual bands (based on calculated mass
determined via mass spectrometry): 1-Defa4 (recombinant); 2,7-Defa5;
3,8-Defa24; 4,9-Defa20/Defa21; 5,10-Defa2; and 6,11-Defa22.
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The differing α-defensin expression results demonstrated by
our analysis versus those previously reported8 likely stem from
the variability of mouse background used in the former study.
Numerous investigations demonstrate that B6 and 129 mouse
strains possess distinct α-defensin profiles and antimicrobial
properties.10 21 26 Such findings underscore the importance of
clearly defining mouse background strain when performing
α-defensin studies. The original Nod2-null mice used to demon-
strate Nod2-dependent α-defensin regulation were constructed
by injecting genetically manipulated 129S1/Sv-derived W9.5 ES
cells into B6 blastocysts. However, no mention of backcrossing
to a pure background strain was indicated, and hence, the
precise background of mice used in the final analysis remains
unclear. Indeed, the detection of Defa4 and Defa-rs10 tran-
scripts in their experimental groups suggests that the mice previ-
ously studied possessed at least a component of the original
129S1/Sv genetic background, as these genes are not found in
B6 strains.10 21 The background ambiguity of these mice leaves
open the possibility that formerly observed differences in
α-defensin expression may be due to variations in mouse strain
between experimental groups, as opposed to a true effect of
Nod2 deficiency.
In the present study, Nod2−/− mice were obtained commer-
cially through Jackson Labs, and represent the original strain
generated by Kobayashi et al that has since been backcrossed to
completion on the B6 background. Using B6 Nod2−/− and WT
littermates, we found no differences in α-defensin expression
between the two groups. The lack of Defa4 and Defa-rs10
expression in both experimental groups is consistent with the
absence of these genes in the B6 mouse strain.10 21 The lack of
Nod2-mediated α-defensin regulation was also true at the
protein level, and could not be explained by differences in PC
number between WT and Nod2−/− mice. Similar to the
α-defensins, there was no evidence of Nod2-driven transcrip-
tional regulation of other AMP classes, including Lyz, Reg3γ
and Ang4, consistent with previous reports.19
Interestingly, the CRS AMP subclasses did display a unique
expression pattern in our experimental groups. CRS peptides
comprise a prominent family of AMPs, which were first
described as PC-specific transcripts that are highly similar to the
Figure 3 Nod2 does not influence Paneth cell (PC) development. (A) H&E staining of ileal tissue shown at 400 × magnification from wild-type
(WT) and Nod2−/− mice was used to quantify intestinal crypts. Panel (B) represents average data from 18–20 high power fields/group (3–4 mice/
group). Panel (C) shows immunohistochemical staining of ileal tissue for lysozyme (Lyz), allowing for the quantification of PCs per crypt. Panel (D)
represents average data from 40–45 crypts/group (5–6 mice/group). (E,F) Flow cytometry was used to measure the percentage of Lyz+ CD45− PCs
from the ileal epithelium of WT and Nod2−/− mice. Data are representative of three independent experiments (NS— not significant, p>0.1, based on
Student’s t test).
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α-defensins.27 These molecules are divided into two primary
groups, CRS1C and CRS4C, based on their C-terminal peptide
sequence.28 CRS4C peptides form homodimers and heterodi-
mers that expand the diversity of AMPs within PC secretions.29
They include Defa-rs10, which was previously reported to be
decreased in Nod2−/− mice relative to WT controls.8 However,
our evaluation of the NIH B6 mouse genome assembly demon-
strated no evidence of the Defa-rs10 gene in B6 animals.10 This
again implies that the background of mice used previously
possessed a non-B6 component. Indeed, we found no transcript
expression of the CRS4C class in either WT or Nod2−/− mice
on a B6 background. Similarly, no mRNA expression of
Defa-rs10 was detected in our experimental groups. This was
confirmed using TaqMan quantitative RT-PCR primers, as well
as the SYBR green primer sequences published originally by
Kobayashi et al.8
By contrast with CRS4C, mRNAs for CRS1C have been
detected in the B6 mouse small intestine.30 Accordingly, we
found a modest ∼25% reduction of CRS1C expression in
Nod2−/− mice relative to WT controls. Although previous work
has suggested a role of Wnt/Tcf-4 signalling in the regulation of
CRS1C expression,31 there have been no reports of Nod2 influ-
encing transcript levels of these molecules. However, despite
finding slightly reduced CRS1C expression in Nod2−/− mice, our
examination of the promoter region of the CRS peptide genes
revealed no canonical NF-κB binding sites (data not shown).
Therefore, the direct effect of Nod2 on CRS1C mRNA expres-
sion remains unclear. Moreover, to our knowledge, CRS1C pep-
tides have not been characterised or detected at the protein level.
Therefore, it is unclear what effect this reduction in CRS1C gene
expression may have on the bactericidal activity of PC secretions.
It is important to underscore that the present study focuses
on Nod2-mediated regulation of PC AMP production, and does
not examine the effects of Nod2-deficiency on PC secretion. It
has been established that the ligand for Nod2, muramyl dipep-
tide (MDP), is a PC secretagogue.3 Subsequent work has sup-
ported this premise, demonstrating decreased bactericidal
activity of Nod2-deficient intestinal crypt secretions stimulated
by MDP.32 Furthermore, Nod2-deficiency also interfered with
carbamyl-choline (CCh)-mediated PC secretion, suggesting that
Nod2 may affect a common inductive signalling pathway for PC
secretion. A presumptive link between Nod2 and global PC
secretion has been made via the molecule KCNN4, which is an
established risk allele for CD.33 Specifically, the mouse homo-
logue of KCNN4 (Kcnn4) is a K+ channel that regulates Ca2+
flux within PCs.34 Patients with NOD2 risk polymorphisms
display reduced levels of KCNN4 mRNA expression, leading to
the hypothesis that Nod2-dysfunction may depress PC secretion
Figure 4 Antimicrobial activity of Paneth cell α-defensins is
unaffected by Nod2. (A) wild-type (WT) and Nod2−/− mouse-derived
ileal protein extracts were resolved by acid urea-polyacrylamide gel
electrophoresis. An excised gel strip containing the α-defensins was
placed onto bacteria-laden agarose. Bacterial clearance zones are
shown for (B) Escherichia coli NC101, (C) Listeria monocytogenes
10403S, and (D) Salmonella enterica serovar Typhimurium. Similarly
sized zones of bacterial growth inhibition are seen for all bacterial
strains, regardless of Nod2 status.
Figure 5 Local cage environment overrides Nod2-mediated influences
on the intestinal microbiota. Principal coordinates analysis (PcoA) using
the first two coordinates of a PcoA based on Bray-Curtis dissimilarity of
454 sequences of 16S rRNA from stool samples. Nod2−/− mice (KO) are
indicated by circles, while wild-type (WT) mice are shown with squares.
The numbers by each symbol indicate the cage of the animal, and each
cage is depicted in a unique colour. PC, principal coordinate.
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by downregulating the expression of this potassium channel.33
Interestingly, we found no differences in Kcnn4 transcript levels
in WT and Nod2−/− mice (data not shown). Nevertheless, a
regulatory effect of Nod2 on PC secretion cannot be ruled out
by the present study.
Even if we stipulate that Nod2-deficiency may result in some
degree of defective PC secretion, the present study raises ques-
tions as to the biological relevance of such impairments.
Previous work using Mmp7−/− mice that possess reduced
α-defensin activity demonstrated profound shifts in the gut
microbiota of these animals.4 Similar alterations of the intestinal
microbiota would be expected in Nod2−/− mice, if these mice
indeed possess impaired PC function. Previous studies have sup-
ported this concept, demonstrating increased levels of
Bacteroides and Firmicutes bacteria in the ilea of Nod2−/− mice
relative to WT controls,32 as well as global alterations of Nod2−/−
gut microbial communities analysed by high-throughput pyrose-
quencing.11 24 While these studies did control for background
strain by using pure B6 mice, the precise breeding and hus-
bandry conditions were often unclear. When such conditions
were clearly described (as in the case for Rehman et al),11
Nod2−/− and WT colonies were housed independently through
the course of the study. While this approach can offer some
insight into the effects of Nod2 on gut microbial composition,
it is limited in its ability to detect confounding cage or mater-
nally transmitted effects on the structure of gut bacterial com-
munities. This is elegantly demonstrated in a recent study by
Ubeda et al,35 which examined gut microbial composition in
MyD88- and TLR-deficient mice. Importantly, this study ana-
lysed the intestinal microbiota of knockout (KO) mouse colonies
that had been housed and bred in isolation, but also evaluated
WT and KO littermates which were housed together prior to
necropsy (similar to the strategy used in the present study).
Their analysis revealed marked differences in the microbiota of
mice from the independent mouse colonies, but minimal altera-
tions in cohoused littermates. This supports the results of our
study, which shows no apparent differences in gut microbial
composition between cohoused Nod2−/− and WT littermates.
The lack of observed Nod2-dependent intestinal microbial
alterations in the present study may be explained by two pos-
sible causes. First, local cage environment (including copropha-
gia) may be a strong influence on faecal microbial composition,
able to suppress differences in the microbial community caused
by genotype. Second, there may be a strong maternal influence
on the faecal microbiota. This would lead to similar microbial
profiles within individual mice of the same litter, regardless of
genotype. Such effects have also been extensively described in
the literature.35 36 Because our study design involved housing
mice of the same litter within the same cage, we were unable to
distinguish cage and litter effects in this study. In either case,
there appears be a strong cage and/or litter effect that super-
sedes the influences of Nod2 on faecal microbial composition.
The findings described in the present study have important
clinical implications. First, numerous human CD risk alleles
have been associated with PC abnormalities,6 37–39 suggesting
an important role for these cells in CD pathogenesis.40
However, to translate such findings to clinical practice, the
mechanisms of these gene-mediated PC impairments must be
elucidated. Mouse models provide an opportunity to study such
mechanisms.41 In this study, we have established a paradigm for
studying PCs in mouse models of CD risk allele dysfunction,
highlighting the importance of controlling for mouse back-
ground and housing conditions in such investigations. Second,
our data raise concerns with the commonly accepted hypothesis
that NOD2 dysfunction leads to attenuated PC microbicidal
activity, which in turn, alters the composition of the gut micro-
biota, thereby predisposing to the development of CD. This
highlights the importance of identifying alternative roles of
NOD2 in the control of intestinal inflammation, both within
PCs as well as other components of the innate immune system.
An elegant approach to characterising such functions will be to
examine PC function in knock-in mice carrying the human






1 16.89 0.10 0.22
2 29.38 1.57E-06 2.35E-05
3 36.01 2.49E-05 1.87E-04
4 40.87 4.83E-05 2.41E-04
5 45.47 0.15 0.29
6 50.00 1.98E-04 7.42E-04
7 54.07 0.15 0.26
8 57.98 0.0012 0.0035
9 61.16 0.84 0.90
10 64.19 0.61 0.76
11 67.05 0.23 0.33
12 69.87 0.28 0.39
13 72.40 0.63 0.73
14 74.84 0.91 0.91
15 77.04 0.02 0.06
p Values are calculated using a one-way analysis of variance in which the null
hypothesis is that cage has no effect on the distribution of the coordinate. The results
for the first 15 coordinates of the Bray–Curtis analysis shown in figure 5 are depicted.
Only cages that had at least three animals were included in the analysis (n=7 cages).
The ‘Multiple Testing Correction’ column shows correction for multiple hypothesis
testing (in this case testing 15 coordinates) using the Benjamini and Hochberg
procedure. For coordinates reaching statistical significance by multiple testing
(p<0.05), the null hypothesis is rejected, indicating that the mouse cage appears to
have an effect on gut bacterial composition.






1 16.89 0.77 0.89
2 29.38 0.26 0.99
3 36.01 0.11 1.62
4 40.87 0.92 0.99
5 45.47 0.68 0.85
6 50.00 0.97 0.97
7 54.07 0.56 0.94
8 57.98 0.31 0.78
9 61.16 0.31 0.92
10 64.19 0.24 1.20
11 67.05 0.58 0.87
12 69.87 0.34 0.74
13 72.40 0.12 0.93
14 74.84 0.44 0.83
15 77.04 0.58 0.79
p Values are calculated using the median values for WT (n=13) and KO (n=14) for
animals in each cage (n=1–3 animals per cage) for a t test in which the null
hypothesis is that host genotype has no effect on the distribution of the coordinate.
The results for the first 15 coordinates of the Bray–Curtis analysis shown in figure 5
are depicted. The ‘Multiple Testing Correction’ column shows correction for multiple
hypothesis testing (in this case testing 15 coordinates) using the Benjamini and
Hochberg procedure. No components reach statistical significance (p<0.05) indicating
that the null hypothesis is accepted for all components, suggesting that Nod2
genotype has minimal effect on gut bacterial composition.
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NOD2 SNP13 polymorphism, which have been described previ-
ously.42 Finally, we demonstrate that environmental factors may
overcome genetic influences on gut microbial structure.
Ultimately, if we hope to modulate intestinal microbial commu-
nities as a treatment strategy for CD, it will be imperative to
override the impact of host genetics on the gut microbiota. The
homogenisation of the intestinal microbiota of Nod2−/− mice
and their WT littermates suggests that strong environmental
pressures may supersede gene-based influences on gut microbial
composition. Future studies should focus on identifying specific
environmental factors that can overcome the microbial effects of
distinct CD risk alleles. This may lead to novel, patient-specific
treatment strategies for this disease.
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